![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/4035 | |
A61K 38/13 | |||
A61K 45/06 | |||
A61K 38/17 | |||
A61K 39/395 | |||
A61K 31/10 | |||
A61K 31/165 | |||
A61K 31/40 | |||
A61K 31/4015 | |||
A61K 31/519 |
(11) | Patento numeris | 2701701 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 12719228.4 |
Europos patento paraiškos padavimo data | 2012-04-27 | |
(97) | Europos patento paraiškos paskelbimo data | 2014-03-05 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-24 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2012/035359 |
Data | 2012-04-27 |
(87) | Numeris | WO 2012/149251 |
Data | 2012-11-01 |
(30) | Numeris | Data | Šalis |
201161480263 P | 2011-04-28 | US |
(72) |
SCHAFER, Peter, US
GANDHI, Anita, US
CAPONE, Lori, US
|
(73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
(54) | METHODS AND COMPOSITIONS USING PDE4 INHIBITORS FOR THE TREATMENT AND MANAGEMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES |
METHODS AND COMPOSITIONS USING PDE4 INHIBITORS FOR THE TREATMENT AND MANAGEMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES |